My husband Ralph is in his 4th day of a First In Human clinical trial at NIH.  He is patient #3.  My last update was Day zero:  T-Cell Infusion Day.

So far, so good.  Everyone is pleasantly surprised how well he is tolerating the IL2.

Today during morning rounds Ralph had another room full of doctors. Thursdays are what they call “Grand Rounds” meaning EVERYONE makes rounds together on patients including doctors, nurses, unit administration, pharmacist, social worker, etc. The main doctor on the trial usually does not round daily, the attending physician rounds and then reports back. We’re told that everyone on the team is in the loop at all times.  There is constant communication among all the members.

Dr. Childs is the main doctor and principal investigator of this trial.  He is  very pleased with Ralph’s progress on the trial.  His labs are good and he’s tolerating the IL2 infusions better than expected. He received his 7th IL2 infusion today at noon, only 7 more to go.  IL2 is called the food for the T-cells.

Later in the afternoon, his nurse noticed that one arm looked swollen.  They took an ultrasound and determined that he has a clot in each arm.  He will now go on Heperin, an anti-coagulant.  Dr. Childs reassured Ralph this is not a big deal and will not interfere with the trial protocol.

Thus far from our experience at NIH, Ralph has received excellent care.  Although at times I think he feels like he’s under a microscope.  But let’s not forget why he is here, to hopefully find a cure and to advance science for all mankind.  After all, NIH could also stand for National Institutes of HOPE.

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Dr. Brandon Manley: Physician, Scientist, Advocate

Dr. Brandon Manley: Physician, Scientist, Advocate

Brandon Manley, M.D., is a urologic oncologist who specializes in genitourinary oncology, with a focus on patients with kidney cancer. He currently practices at Moffitt Cancer Center in Tampa, Florida, where he lives with his wife Aimee, and his two daughters Sadie and Brooklyn. The family enjoys...

DISTRICT DAYS 2022 →

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Dr. Brandon Manley: Physician, Scientist, Advocate

Dr. Brandon Manley: Physician, Scientist, Advocate

Brandon Manley, M.D., is a urologic oncologist who specializes in genitourinary oncology, with a focus on patients with kidney cancer. He currently practices at Moffitt Cancer Center in Tampa, Florida, where he lives with his wife Aimee, and his two daughters Sadie and Brooklyn. The family enjoys...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING YOUR CARE TEAM

TREATMENT & TRIAL OPTIONS
LIVING WELL WITH KIDNEY CANCER

CLINICAL TRIALS →

IMMUNOTHERAPY →

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Dr. Brandon Manley: Physician, Scientist, Advocate

Dr. Brandon Manley: Physician, Scientist, Advocate

Brandon Manley, M.D., is a urologic oncologist who specializes in genitourinary oncology, with a focus on patients with kidney cancer. He currently practices at Moffitt Cancer Center in Tampa, Florida, where he lives with his wife Aimee, and his two daughters Sadie and Brooklyn. The family enjoys...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...